Tag Archives: Implantable Medical Devices Market

Growing Preference for Titanium Alloys and Zirconium to Reshape Future of Implantable Medical Devices, reports TMR

The global implantable medical devices market features a largely consolidated competitive landscape, with the top five companies accounting for a share of more than 50% in 2015, reports TMR in a recent report. These companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, Institut Straumann AG, hold sway owing to innovation, rapid introduction of newer and more effective product varieties, and presence across several key regional markets. Being a technology- and research-intensive field, governed by stringent approval regulations, the implantable medical devices market faces a low threat of new entrants in the next few years. However, the introduction of more promising substitutes to traditionally used materials is expected to intensify competition.

 

Transparency Market Research estimates that the global implantable medical devices market will witness expansion at a healthy 4.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$32.3 bn in 2015, is expected to rise to US$49.8 bn by 2024. Of the key materials used for manufacturing medical implants, titanium is presently the most preferred but is expected to lose its prominence to other options such as titanium alloys and zirconium. Over the period between 2016 and 2024, the market for titanium implants is expected to expand at a 4.7% CAGR. The markets for titanium alloy implants and zirconium implants are expected to expand at 5.5% and 6.4% CAGR over the same period, respectively.

 

Read Full Report: http://www.transparencymarketresearch.com/global-implantable-medical-devices-market.html

 

Rising Prevalence of Chronic Degenerative Disease and Dental Problems to Stimulate Demand for Implantable Medical Devices Globally

 

A plethora of factors are boosting the global consumption of medical implantable devices. Some of the chief ones of these are the rising numbers of people suffering from chronic degenerative diseases such as arthritis and cardiovascular issues and the high prevalence of dental problems, which could require orthodontic and periodontics interventions. While busy lifestyles, unhealthy dietary habits, lack of physical activities, and rising geriatric population are triggering chronic health diseases, the rising intake of junk/fast food is leading to the increased incidences of dental issues. Over the next few years, these factors are expected to arise as high-impact drivers of the global implantable medical devices.

 

Along with these factors, the rising prevalence of a number of congenital diseases and the increased awareness and consciousness regarding body’s appearance, and the alleged boost to self-esteem that cosmetic surgeries bring, have also been underlined as the key drivers of the global implantable medical devices market. The increased awareness regarding body aesthetics has given a huge boost to the market for dental surgeries involving implantations, thus driving the global implantable medical devices market.

 

Concerns Regarding Corrosion, Developments in Surgical Field Threaten to Hurt Demand for Conventional Implants

 

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13946

 

Studies have demonstrated that implants made from materials such as nickel and chromium are prone to corrosion and can trigger cancers. Implants made from cobalt alloy are known to pose risks to human health owing to in vivo ion release; polyethylene implants could be a potential trigger for bone lysis and localized tissue ruptures. Owing to the potential health issues that many varieties of implants cause, patients are more prone to opt for other alternatives. Along with this, the vast developments in the surgical field could also stimulate the consumer to prefer surgeries that promise minimal risk to health.

 

Moreover, the high costs of medical implants and the concerns regarding post-implantation infections, which may add to the overall cost of implanting a medical device in the body, are also restraining the overall growth prospects of the global implantable medical devices market to a certain extent.

 

This review is based on a recent report by Transparency Market Research, titled “Implantable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 – 2024.”

 

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Implantable Medical Devices Market: Advanced technologies & growth opportunities in global Industry by 2024

The global implantable medical devices market features a largely consolidated competitive landscape, with the top five companies accounting for a share of more than 50% in 2015, reports TMR in a recent report. These companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, Institut Straumann AG, hold sway owing to innovation, rapid introduction of newer and more effective product varieties, and presence across several key regional markets. Being a technology- and research-intensive field, governed by stringent approval regulations, the implantable medical devices market faces a low threat of new entrants in the next few years. However, the introduction of more promising substitutes to traditionally used materials is expected to intensify competition.

Transparency Market Research estimates that the global implantable medical devices market will witness expansion at a healthy 4.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$32.3 bn in 2015, is expected to rise to US$49.8 bn by 2024. Of the key materials used for manufacturing medical implants, titanium is presently the most preferred but is expected to lose its prominence to other options such as titanium alloys and zirconium. Over the period between 2016 and 2024, the market for titanium implants is expected to expand at a 4.7% CAGR. The markets for titanium alloy implants and zirconium implants are expected to expand at 5.5% and 6.4% CAGR over the same period, respectively.

Read Full Report: http://www.transparencymarketresearch.com/global-implantable-medical-devices-market.html

Rising Prevalence of Chronic Degenerative Disease and Dental Problems to Stimulate Demand for Implantable Medical Devices Globally

A plethora of factors are boosting the global consumption of medical implantable devices. Some of the chief ones of these are the rising numbers of people suffering from chronic degenerative diseases such as arthritis and cardiovascular issues and the high prevalence of dental problems, which could require orthodontic and periodontics interventions. While busy lifestyles, unhealthy dietary habits, lack of physical activities, and rising geriatric population are triggering chronic health diseases, the rising intake of junk/fast food is leading to the increased incidences of dental issues. Over the next few years, these factors are expected to arise as high-impact drivers of the global implantable medical devices.

Along with these factors, the rising prevalence of a number of congenital diseases and the increased awareness and consciousness regarding body’s appearance, and the alleged boost to self-esteem that cosmetic surgeries bring, have also been underlined as the key drivers of the global implantable medical devices market. The increased awareness regarding body aesthetics has given a huge boost to the market for dental surgeries involving implantations, thus driving the global implantable medical devices market.

Concerns Regarding Corrosion, Developments in Surgical Field Threaten to Hurt Demand for Conventional Implants

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13946

Studies have demonstrated that implants made from materials such as nickel and chromium are prone to corrosion and can trigger cancers. Implants made from cobalt alloy are known to pose risks to human health owing to in vivo ion release; polyethylene implants could be a potential trigger for bone lysis and localized tissue ruptures. Owing to the potential health issues that many varieties of implants cause, patients are more prone to opt for other alternatives. Along with this, the vast developments in the surgical field could also stimulate the consumer to prefer surgeries that promise minimal risk to health.

Moreover, the high costs of medical implants and the concerns regarding post-implantation infections, which may add to the overall cost of implanting a medical device in the body, are also restraining the overall growth prospects of the global implantable medical devices market to a certain extent.

This review is based on a recent report by Transparency Market Research, titled “Implantable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 – 2024.”

 

Implantable Medical Devices Market will expand at a healthy CAGR of 4.9% over the period between 2016 and 2024

Transparency Market Research estimates that the global implantable medical devices market will witness expansion at a healthy 4.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$32.3 bn in 2015, is expected to rise to US$49.8 bn by 2024. Of the key materials used for manufacturing medical implants, titanium is presently the most preferred but is expected to lose its prominence to other options such as titanium alloys and zirconium. Over the period between 2016 and 2024, the market for titanium implants is expected to expand at a 4.7% CAGR. The markets for titanium alloy implants and zirconium implants are expected to expand at 5.5% and 6.4% CAGR over the same period, respectively.

The global implantable medical devices market features a largely consolidated competitive landscape, with the top five companies accounting for a share of more than 50% in 2015, reports TMR in a recent report. These companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, Institut Straumann AG, hold sway owing to innovation, rapid introduction of newer and more effective product varieties, and presence across several key regional markets. Being a technology- and research-intensive field, governed by stringent approval regulations, the implantable medical devices market faces a low threat of new entrants in the next few years. However, the introduction of more promising substitutes to traditionally used materials is expected to intensify competition.

Read Full Report: http://www.transparencymarketresearch.com/global-implantable-medical-devices-market.html

Rising Prevalence of Chronic Degenerative Disease and Dental Problems to Stimulate Demand for Implantable Medical Devices Globally

A plethora of factors are boosting the global consumption of medical implantable devices. Some of the chief ones of these are the rising numbers of people suffering from chronic degenerative diseases such as arthritis and cardiovascular issues and the high prevalence of dental problems, which could require orthodontic and periodontics interventions. While busy lifestyles, unhealthy dietary habits, lack of physical activities, and rising geriatric population are triggering chronic health diseases, the rising intake of junk/fast food is leading to the increased incidences of dental issues. Over the next few years, these factors are expected to arise as high-impact drivers of the global implantable medical devices.

Along with these factors, the rising prevalence of a number of congenital diseases and the increased awareness and consciousness regarding body’s appearance, and the alleged boost to self-esteem that cosmetic surgeries bring, have also been underlined as the key drivers of the global implantable medical devices market. The increased awareness regarding body aesthetics has given a huge boost to the market for dental surgeries involving implantations, thus driving the global implantable medical devices market.

Concerns Regarding Corrosion, Developments in Surgical Field Threaten to Hurt Demand for Conventional Implants

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13946

Studies have demonstrated that implants made from materials such as nickel and chromium are prone to corrosion and can trigger cancers. Implants made from cobalt alloy are known to pose risks to human health owing to in vivo ion release; polyethylene implants could be a potential trigger for bone lysis and localized tissue ruptures. Owing to the potential health issues that many varieties of implants cause, patients are more prone to opt for other alternatives. Along with this, the vast developments in the surgical field could also stimulate the consumer to prefer surgeries that promise minimal risk to health.

Moreover, the high costs of medical implants and the concerns regarding post-implantation infections, which may add to the overall cost of implanting a medical device in the body, are also restraining the overall growth prospects of the global implantable medical devices market to a certain extent.

This review is based on a recent report by Transparency Market Research, titled “Implantable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 – 2024.”

 

Implantable Medical Devices Market: Industry Players Shifting Focus towards Developing Economies

The global market for implantable medical devices is expected to witness steady growth, in terms of both volume and revenue, in the next few years. The vast rise in incidence of musculoskeletal, dental, and a vast number of chronic degenerative health conditions are boosting the overall global demand for a variety of implantable medical devices globally. The rising geriatric population, increased affordability, and the trend of increasing expenditures aimed at maintaining health and longevity are also boosting the growth of the global implantable medical devices market globally.

Transparency Market Research estimates that the global implantable medical devices market will expand at a healthy CAGR of 4.9% over the period between 2016 and 2024. At this pace, the market is expected to rise to US$49.8 bn in 2024 from a valuation of US$32.3 bn in 2015.

Titanium Implants to Lose Ground to Titanium Alloys and Zirconium Implants

Of the key materials used for manufacturing implantable medical devices, titanium is presently the largest contributor to the global market’s overall revenues, accounting for a share of 42% in 2015. However, the segment is projected to witness a slight decline in its share in the global market to the segment of titanium alloys over the said period. The segment of titanium implants is expected to exhibit a 4.7% CAGR while the segment of titanium alloy implants is expected to expand at a 5.5% CAGR over the period between 2016 and 2024.

The segment of zirconium implants is expected to emerge as the one with the most promising growth opportunities over the said period. The segment is expected to expand at the fastest CAGR of 6.4% from 2016 to 2024 as compared to other prominently used materials for manufacturing implantable medical devices. The advantage of one-piece zirconium implants that they don’t catch bacterial growth or do not suffer gradual degradation by electrochemical attacks, owing to the absence of any prosthetic connections, is expected to work in their favor and reduce the reliance on titanium implants, which mostly have these disadvantages. The same factor is also expected to work in the favor of titanium alloys and bring a decline in the overall use of titanium for the manufacture of medical implants.

Asia Pacific Implantable Medical Devices Market to Post Considerable Gains

North America is presently the leading contributor to the global implantable medical devices market’s revenues in 2015, accounting for a share of nearly 42%. The region is also expected to retain its dominance in the global market over the forecasting horizon. Factors such as the well-established healthcare facilities, rising geriatric population, effective reimbursement policies, high purchasing power, and rising numbers of obese people will play a key role in bringing this estimate into effect. The U.S. is the most eminent national market for implantable medical devices in the region, accounting for over 92% of the North America IMD market in 2015.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13946

However, the North America market is expected to lose prominence to the Asia Pacific IMD, which is expected to expand at the fastest pace over the period between 2016 and 2024. The factors that are expected to boost the overall consumption of implantable medical devices in Asia Pacific in the next few years include the rising population of affluent consumers, improving healthcare infrastructure, booming medical tourism industry, and rising focus and expenditure on healthcare and wellness.

Japan is the most prominent country for implantable medical devices in Asia Pacific and the second-largest country-wise market across the globe. Japan’s market for implantable medical devices is expected to expand at a favorable pace over the period between 2016 and 2024 as well. Factors such as the country’s vast geriatric population, rising prevalence of orthopedic conditions, and the continuous rise in demand for advanced technologies in the healthcare industry will contribute to the increased demand for implantable medical devices in the country.

The market features a largely consolidated competitive landscape, with the top five companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, and Institut

Straumann AG, commanding a more than 50% share of the global market in 2015. Other key vendors in the market include Smith & Nephew plc, Danaher Corporation, Abbott Laboratories, Dentsply Sirona, and Boston Scientific Corporation.